1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Rolling deadlines: new applications due February 12, June 12, October 12; resubmissions due March 12, July 12, November 12; AIDS applications due May 7, September 7, January 7.
"Mentored Research Scientist Development Award (K01)" is currently closed and not accepting applications.
Mentored Research Scientist Development Award (K01) is sponsored by National Institutes of Health (NIH). The NIH K01 award is designed for investigators with a research doctoral degree who need additional mentored research experience. It is appropriate for scientists who have completed postdoctoral training but are not yet ready for independent funding, providing support for intensive research and career development.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Mentored Research Scientist Development Award (K01) - National Institute of Mental Health (NIMH) NIH Websites Are Changing Opportunities & Announcements Funding Strategy for Grants Grant Writing & Approval Process Mentored Research Scientist Development Award (K01) The NIH Mentored Research Scientist Development Award (K01) provides support and “protected time” (3-5* years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence.
The expectation is that, through this sustained period of research career development and training, awardees will launch independent research careers.
*See Additional Information below regarding duration of support PA-24-175: Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) PA-24-176: Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) PA-24-177: Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental Studies with Humans Required) Learn more about NIH’s Definition of a Clinical Trial .
New Applications: February 12, June 12, October 12 Resubmissions: March 12, July 12, November 12 AIDS applications: May 7, September 7, January 7 By the time of award, the applicant must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status).
U.S. domestic institutions Foreign components allowed An application must include a strong and credible plan for the applicant’s transition to research independence and evidence of significant institutional commitment to the continued development of the K01 applicant as an independent researcher at the applicant institution.
Applicants are expected to plan to apply for independent research support (e.g., R01) during the later years of their mentored career award. Applicants are required to commit a minimum of 75% of full-time professional effort to their program of career development.
Applicants may engage in other duties as part of the professional effort not covered by this award, as long as such duties do not interfere with or detract from the proposed career development program. NIMH encourages applicants to limit the requested support to no more than four years.
If they are proposing more than four years of support, applicants are strongly encouraged to contact an NIMH Research Training and Career Development Program Officer .
Program staff will evaluate whether the requested duration of support is appropriately justified, taking into consideration prior research experience, the extent and duration of needed career development activities, and the timeline needed to complete the proposed research activities. Applications requesting five years of support without pre-submission approval may be programmatically reduced to four years of support.
Salary and research support Salary support: Up to $90,000 plus fringe benefits per year. Research support: Up to $50,000 per year. The NIMH will support a salary allowance that is commensurate with the actual level of effort, up to the allowable cap for that program, based on a full-time, 12-month position.
The requested salary must be consistent both with the established salary structure at the institution and with salaries provided by the institution from its own funds to other staff members with equivalent qualifications, rank, and responsibilities in the department concerned. The recipient institution may supplement the NIH salary contribution up to a level that is consistent with the institution's salary scale.
The total salary may not exceed the legislatively mandated salary cap . Potential applicants are strongly encouraged to review the funding opportunity and the FAQs below prior to contacting the appropriate NIMH Research Training and Career Development representative for additional information. To compare across K mechanisms (i.e., salary support, effort, etc.), see the Table of K Parameters .
Have additional questions? N Career Development Programs (K-Series) NIH Research Training and Career Development FAQs NIMH Guidance for Responsible Conduct of Research (RCR) Training Requirements Q: I am proposing to serve as the lead investigator of an independent clinical trial and may need to request a longer project duration (>4 years) for scientific reasons. How will the NIMH determine if the duration of support is justified?
A: Some scientific considerations that may justify a longer project duration include the number of human subjects required to provide adequate power, the rate of subject recruitment, or the need for follow-up. Q: Can I apply if I am on a temporary visa?
A: You may apply but must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status) at the time of the award. Check the U.S. State Department website for current guidance on processing times.
(NIMH time from application submission to award is typically 8-9 months.) Q: How many times may I resubmit? A: Only a single resubmission (A1) of a competing new application (A0) will be accepted.
However, you may submit another A0 application if the A1 is not selected for funding and you are still within the 6-year period of eligibility. Q: Should I apply for a K01 or an R21? A: You should apply for a K01 if you require significant training in order to transition to independence.
An R21 is appropriate for exploratory and high-risk research projects that may lead to a breakthrough or the development of novel techniques, agents, methods, measures, models, strategies, or to the generation of pilot or feasibility data. Q: How many mentors should I include in my training plan? A: The number of mentors should be driven by the training needs.
Mentors with overlapping expertise should generally not be included, especially in the case where an individual is included based on their status rather than their direct involvement in the project and training. Q: Are consultants appropriate for a K award? A: It depends.
Consultants are individuals who provide advice or services for a fee. There may be some circumstances where a consultant is appropriate for a K Award, but in the context of a training and career development award, if you expect them to teach you something, they’re probably a mentor or collaborator. Q: How many publications do I need for a competitive application?
A: There is no set number of publications, but publications help reviewers evaluate the applicant according to Section V (Application Review Information) of the program announcement.
That is, they help to determine the potential of the applicant to develop as an independent and productive researcher, whether the applicant's prior training and research experience is appropriate for this award, and whether the applicant’s academic, clinical (if relevant), and research record is of high quality.
Publications may also serve to demonstrate feasibility for aspects of the projects that the applicant has already mastered.
According to the current listing, eligibility includes: Investigators with a research doctoral degree (e.g., PhD) who require intensive mentored training to develop research independence, or who want to resume their research career after a hiatus. Confirm the full requirements in the official notice before applying.
Mentored Research Scientist Development Award (K01) accepts applications on a rolling basis — there is no single fixed deadline. Check the official notice for any cycle-specific review dates.
Mentored Research Scientist Development Award (K01) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article